Press Coverage

October 13, 2019

MOPEAD partners meet in Cologne for final Consortium Meeting

MOPEAD partners from the University of Cologne hosted the 5th and last project Consortium meeting in their premises in Cologne (Germany), on the 1st and 2nd October 2019. The meeting was an opportunity for the Consortium members to hear about the project results at this very point in time and discuss their finalisation and dissemination . . .

July 21, 2019

Interim analysis of MOPEAD's online recruitment strategy presented at AAIC 2019

Cambridge Cognition attended the Alzheimer’s Association International Conference this month in Los Angeles (USA) and presented a poster showing an interim analysis of the online screening as a recruitment strategy if the Models of Patient Engagement in Alzheimer’s disease (MOPEAD) project . . 

June 13, 2019

The Spanish magazine for geriatric care professionals, GeriatricArea, recently published an article on MOPEAD highlighting it's nomination for the 2019 Internet Awards.

May 06, 2019

MOPEAD Project to be published in Azheimer's & Dementia: The Journal of the Alzheimer's Association

Today, the renowned journal Alzheimer's & Dementia: The Journal of the Alzheimer's Association published an article on the foundations and the structure of the MOPEAD (Models Of Patient Engagement for Alzheimer’s Disease) project.

[Read it: https://bit.ly/2V4KnI1]

May 06, 2019

Članek o Projektu MOPEAD v reviji Alzheimer's & Dementia: The Journal of the Alzheimer's Association

Danes je v priznani strokovni reviji Alzheimer's & Dementia, ki jo izdaja Alzheimer's Association iz Velike Britanije, objavljen članek o temeljih in strukturi projekta MOPEAD (Modeli vključevanja bolnikov z Alzheimerjevo boleznijo). [https://bit.ly/2V4KnI1]

November 15, 2018

Download the press release 

October 04, 2018

MOPEAD Press release: Patient recruitment for MOPEAD gathers speed

Download press release

October 04, 2018

MOPEAD Press release: MOPEAD Consortium meets in Barcelona

Download the Press Release

July 08, 2018

MOPEAD featured in Pharma Fakten

The MOPEAD project has been featured in Pharma Fakten.  Pharma Fakten is an initiative taken by pharmaceutical companies in Germany to provide quick and accurate information to the general public on current topics of interest to the pharmaceutical industry.

May 10, 2018

MOPEAD Press release : University of Cologne begins patient recruitment for the MOPEAD project

Download the press release

May 09, 2018

MOPEAD Press release : Fundacio ACE begins patient recruitment for the MOPEAD project

Download the press release

December 18, 2017

MOPEAD discussed at Alzheimer Europe's third Alzheimer’s Association Academy

MOPEAD illustrates how it can support earlier diagnosis of Alzheimer’s disease and dementia at Alzheimer Europe's third Alzheimer’s Association Academy

December 18, 2017

MOPEAD presented at Alzheimer Europe’s European Parliament lunch debate

The MOPEAD project was presented at Alzheimer Europe’s European Parliament lunch debate focussing on improving the diagnosis of Alzheimer’s disease thanks to European research collaboration.

November 04, 2017

MOPEAD present at the CTAD conference in Boston

This year MOPEAD was at the CTAD Conference in Boston. A Focus Panel titled “Pre-screening Initiatives to Identify Individuals with Preclinical or Early Alzheimer’s disease for Clinical Trials” discussed mechanisms to identify individuals with earlier-stage disease in the general population and in primary care settings, communicate the nature of clinical research, expedite evaluation at the research site, and ensure good communication with primary care providers.

October 04, 2017

The MOPEAD consortium discusses project's progress in Berlin

The MOPEAD Consortium met in Berlin on 04/05 October 2017 after the Alzheimer Europe annual conference. The Consortium also invited a pool of external Advisors who enriched the MOPEAD implementation plan with their insight.

October 03, 2017

MOPEAD presented during the Alzheimer Europe annual conference in Berlin

Alzheimer Europe organised a Symposium supported by Eli Lilly on 4 October 2017 at its annual conference in Berlin. The symposium titled “Engaging with Patient Organizations within the IMI Consortia to inform quality, relevance and value in Alzheimer’s research – insights from MOPEAD, EPAD and ROADMAP" explored how these three public-private consortia sponsored by Horizon 2020 under the auspices of IMI and EFPIA, are tackling AD across its continuum.

April 05, 2017

Fundacio ACE in ACRA

The role of Fundacio ACE in two EU-funded projects, including MOPEAD, is highlighted in acractiva, a magazine edited by ACRA, the Catalan Association of Assistance Resources.

March 31, 2017

Interview in Dementia Europe

Dementia Europe's April edition featured an interview with with Laura Campo and Dr. Mercè Boada, where they talk about the ideas behind MOPEAD.

March 28, 2017

European Patients' Forum

Annette Dumas, ASDM Consulting, presents MOPEAD on the European Patients’ Forum blog 

February 13, 2017

MOPEAD in the Slovenian press

Dr Milica Kramberger from MOPEAD partner organisation University Medical Centre Ljubljana talks to leading Slovenian newspaper Delo about early detection of Alzheimer's Disease.

February 13, 2017

Q&A with Dr Merce Boada

Defining strategies to overcome obstacles to early diagnosis and treatment in Alzheimer’s disease: MOPEAD

Today’s post comes from Mercè Boada, Founder and Medical Director of Fundació ACE, Institut Català de Neurociències Aplicades

February 06, 2017

MOPEAD engages citizens to seek early diagnosis for Alzheimer’s disease

GeriatricArea, a Spanish on-line information site for geriatricians,  presents MOPEAD : El proyecto MOPEAD busca implicar a los ciudadanos en el diagnóstico precoz del Alzheimer (MOPEAD engages citizens to seek early diagnosis for Alzheimer’s disease)

February 03, 2017

MOPEAD featured in La Vanguardia

On 3 February, an article about the MOPEAD project appeared in Spanish daily newspaper La Vanguardia.

January 25, 2017

MOPEAD Press release

Download the first project press release

Please reload

©2018 MOPEAD

This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under Grant Agreement No 115985. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations